Serological evidence of strongyloidiasis in COVID-19 hospitalized patients in northern Iran during the pandemic: prevalence and risk factors
Abstract Strongyloidiasis, a parasitic infection caused by the intestinal nematode Strongyloides stercoralis , remains a significant public health concern in tropical and subtropical regions. This helminthic infection poses particular risks for immunocompromised individuals, potentially progressing to life-threatening hyperinfection syndrome and disseminated disease. In Iran, endemic foci of S. stercoralis have been well-documented in both northern and southern coastal provinces. The current COVID-19 pandemic has introduced new clinical challenges, as immunosuppressive therapies commonly employed in COVID-19 management may predispose patients to severe parasitic complications. This descriptive cross-sectional study aimed to determine both the seroprevalence of S. stercoralis infection and associated risk factors among COVID-19 patients of Guilan province in northern Iran during 2022. A total of 208 serum samples were collected from patients with COVID-19 referred to Razi Hospital in Rasht City, Guilan province. Demographic data, such as sex, age, job, residential area, and educational level, were recorded through interviews. The presence of the anti- S. stercoralis IgG antibody was detected by S. stercoralis IgG ELISA kit. The seropositive rate of strongyloidiasis was 19.7% of all the studied subjects. The seropositivity rate for strongyloidiasis was 19.7% among the studied subjects. A significant difference ( P = 0.039) was observed between genders, with 25.2% of males and 13.9% of females testing seropositive. The prevalence was significantly higher ( P = 0.014) among farmers and workers compared to other occupational groups. Additionally, illiterate individuals had a significantly higher infection rate ( P = 0.007) than those with formal education. This study highlights a high prevalence of strongyloidiasis among COVID-19 patients in northern Iran. Therefore, screening for Strongyloides infection using serologic methods, particularly in endemic regions should be considered before initiating immunosuppressive therapy in COVID-19 patients. Future epidemiological research should systematically evaluate individual risk factors to facilitate targeted intervention strategies.
Authors
- Arash Pourgholaminejad (ORCID: https://orcid.org/0000-0001-6786-3386)
- Meysam Sharifdini (ORCID: https://orcid.org/0000-0003-2686-7748)
- Keyhan Ashrafi (ORCID: https://orcid.org/0000-0002-2102-0284)
- Sara Nemati (ORCID: https://orcid.org/0000-0002-8044-8619)
- Zohreh Fakhrieh-Kashan (ORCID: https://orcid.org/0000-0003-2967-2196)
- Mohammad Haghighi
- Tofigh Yaghubi Kalurazi
- Zahra Atrkar Roushan
- Eshrat Beigom Kia
Institutions
- Guilan University of Medical Sciences (IR)
- Razi Hospital (IR)
- Research Institute for Gastroenterology and Liver Diseases (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Parasitic Diseases
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s12639-026-02018-y
- Primary Topic
- Parasites and Host Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00